Search research articles
Contact Us
Filters
Showing results (61-70 of 124) with videos related to
Page
of 13
Sort By:
Leukemia
|
November 11, 2005
Overcoming MDR-associated chemoresistance in HL-60 acute myeloid leukemia cells by targeting sphingosine kinase-1
E Bonhoure, D Pchejetski, N Aouali, et al.
Molecular Pharmacology
|
August 15, 2001
Glutathione peroxidase-1 overexpression prevents ceramide production and partially inhibits apoptosis in doxorubicin-treated human breast carcinoma cells
V Gouazé, M E Mirault, S Carpentier, et al.
Leukemia
|
January 7, 2006
Caspase-dependent and -independent cell death of Jurkat human leukemia cells induced by novel synthetic ceramide analogs
T Granot, D Milhas, S Carpentier, et al.
Journal of Neurochemistry
|
July 29, 1998
Evidence for the lack of involvement of sphingomyelin hydrolysis in the tumor necrosis factor-induced secretion of nerve growth factor in primary astrocyte cultures
I Galve-Roperh, C Sánchez, B Ségui, et al.
Circulation Research
|
November 22, 2001
Sphingolipid mediators in cardiovascular cell biology and pathology
T Levade, N Augé, R J Veldman, et al.
The Journal of Biological Chemistry
|
August 9, 1996
The sphingomyelin-ceramide signaling pathway is involved in oxidized low density lipoprotein-induced cell proliferation
N Augé, N Andrieu, A Nègre-Salvayre, et al.
The Biochemical Journal
|
April 20, 2001
A neutral sphingomyelinase resides in sphingolipid-enriched microdomains and is inhibited by the caveolin-scaffolding domain: potential implications in tumour necrosis factor signalling
R J Veldman, N Maestre, O M Aduib, et al.
Journal of Lipid Research
|
December 1, 1996
In situ assay of acid sphingomyelinase and ceramidase based on LDL-mediated lysosomal targeting of ceramide-labeled sphingomyelin
T Levade, M Leruth, D Graber, et al.
Journal of the Neurological Sciences
|
December 1, 1995
Neurodegenerative course in ceramidase deficiency (Farber disease) correlates with the residual lysosomal ceramide turnover in cultured living patient cells
T Levade, H W Moser, A H Fensom, et al.
American Journal of Physiology. Regulatory, Integrative and Comparative Physiology
|
November 10, 2005
Reactive oxygen species production by mitochondria in endothelial cells exposed to reoxygenation after hypoxia and glucose depletion is mediated by ceramide
S Therade-Matharan, E Laemmel, S Carpentier, et al.
Page
of 13
Search research articles
Search
Showing results (61-70 of 124) with videos related to
Sort By:
Page
of 13
Leukemia
|
November 11, 2005
Overcoming MDR-associated chemoresistance in HL-60 acute myeloid leukemia cells by targeting sphingosine kinase-1
E Bonhoure, D Pchejetski, N Aouali, et al.
Molecular Pharmacology
|
August 15, 2001
Glutathione peroxidase-1 overexpression prevents ceramide production and partially inhibits apoptosis in doxorubicin-treated human breast carcinoma cells
V Gouazé, M E Mirault, S Carpentier, et al.
Leukemia
|
January 7, 2006
Caspase-dependent and -independent cell death of Jurkat human leukemia cells induced by novel synthetic ceramide analogs
T Granot, D Milhas, S Carpentier, et al.
Journal of Neurochemistry
|
July 29, 1998
Evidence for the lack of involvement of sphingomyelin hydrolysis in the tumor necrosis factor-induced secretion of nerve growth factor in primary astrocyte cultures
I Galve-Roperh, C Sánchez, B Ségui, et al.
Circulation Research
|
November 22, 2001
Sphingolipid mediators in cardiovascular cell biology and pathology
T Levade, N Augé, R J Veldman, et al.
The Journal of Biological Chemistry
|
August 9, 1996
The sphingomyelin-ceramide signaling pathway is involved in oxidized low density lipoprotein-induced cell proliferation
N Augé, N Andrieu, A Nègre-Salvayre, et al.
The Biochemical Journal
|
April 20, 2001
A neutral sphingomyelinase resides in sphingolipid-enriched microdomains and is inhibited by the caveolin-scaffolding domain: potential implications in tumour necrosis factor signalling
R J Veldman, N Maestre, O M Aduib, et al.
Journal of Lipid Research
|
December 1, 1996
In situ assay of acid sphingomyelinase and ceramidase based on LDL-mediated lysosomal targeting of ceramide-labeled sphingomyelin
T Levade, M Leruth, D Graber, et al.
Journal of the Neurological Sciences
|
December 1, 1995
Neurodegenerative course in ceramidase deficiency (Farber disease) correlates with the residual lysosomal ceramide turnover in cultured living patient cells
T Levade, H W Moser, A H Fensom, et al.
American Journal of Physiology. Regulatory, Integrative and Comparative Physiology
|
November 10, 2005
Reactive oxygen species production by mitochondria in endothelial cells exposed to reoxygenation after hypoxia and glucose depletion is mediated by ceramide
S Therade-Matharan, E Laemmel, S Carpentier, et al.
Page
of 13